Wen Yingying Y - OmicsDI

Show results for

Proteomics (4)
Metabolomics (1)

Organisms

Homo sapiens (2)
Rattus rattus (1)

Repository

iProX (3)
MassIVE (1)
MetaboLights (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

Q Exactive (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2022 (3)
2020 (1)
2017 (1)

CHEBI ID

CHEBI:73064 (1)
CHEBI:180850 (1)
CHEBI:185625 (1)
CHEBI:174762 (1)
CHEBI:7102 (1)
CHEBI:168587 (1)
CHEBI:101381 (1)
CHEBI:175372 (1)
CHEBI:176119 (1)
CHEBI:178381 (1)
CHEBI:186675 (1)
CHEBI:6997 (1)
CHEBI:90848 (1)
CHEBI:4838 (1)
CHEBI:186634 (1)
CHEBI:28074 (1)
CHEBI:184503 (1)
CHEBI:169055 (1)
CHEBI:168320 (1)
CHEBI:165758 (1)
CHEBI:183025 (1)
CHEBI:179359 (1)
CHEBI:166568 (1)
CHEBI:69040 (1)
CHEBI:21412 (1)
CHEBI:175448 (1)
CHEBI:178586 (1)
CHEBI:189878 (1)
CHEBI:187087 (1)
CHEBI:165538 (1)

Metabolite Name

O-(11-carboxyundecanoyl)carnitine (1)
N-linoleoyl dopamine (1)
2-(2-Methylbutanoyl)-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one (1)
5-[(E)-2-(4-hydroxyphenyl)ethenyl]-2-[(1E)-3-methylbuta-1,3-dien-1-yl]benzene-1,3-diol (1)
1-dimethylarsinoyl-tricosane (1)
(2E)-4-hydroxy-3-methylbut-2-en-1-yl trihydrogen diphosphate (1)
PA(14:1(9Z)/0:0) (1)
(1xi,2xi)-1-(4-Hydroxyphenyl)-1,2,3-propanetriol 3-O-beta-D-Glucopyranoside (1)
3'-N-Acetyl-4'-O-(14-methylpentadecanoyl)fusarochromanone (1)
Melledonol (1)
3-methyl-tridecanedioic acid (1)
3beta-Hydroxy-5alpha-pregnan-20-one acetate (1)
5-Methoxy-6,7-methylenedioxyflavone (1)
PC(0:0/5:0)[U] (1)
Moricizine (1)
2-(6-{2,4-dihydroxy-3-[(1E)-3-methylbut-1-en-1-yl]benzoyl}-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl)benzene-1,3-diol (1)
MRE-269 (1)
(+)-Erysotrine (1)
5-Methylthioribose 1-phosphate (1)
24-ethyl-5alpha-cholest-25-en-3alpha,12alpha,16alpha-triol (1)
1-O-(2R-methoxy-4Z-eicosenyl)-sn-glycerol (1)
Cyclic dAMP (1)
N-linolenoyl glutamic acid (1)
6,2'4'-Trihydroxy-2-phenylbenzofuran (1)
5S,8R-DiHOME (1)
Trans-2, 3, 4-Trimethoxycinnamate (1)
2-Hexadecanone (1)
SM(d18:1/19:0) (1)
Seselin (1)
PC(0:0/3:1(2E)) (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis

Zhuyu pill (ZYP) is a traditional Chinese medicine prescription composed of two drugs, Coptis chinensis Franch. and Tetradium ruticarpum (A. Jussieu) T. G. Hartley, and is commonly used in the clinical treatment of diseases of the digestive system. However, the mechanism underly...

2022-11-02 | MTBLS4980 | MetaboLights

Human bladder cancer LC MS/MS

Urine is an ideal material to study and examine the bladder cancer (BCa) biomarkers, whereas exploration to the corresponding protein candidates is confronting technique challenges. Herein, we proposed a comprehensive strategy of searching the urine proteins related to BCa. The strategy consists of ...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2017-03-28 | MSV000080696 | MassIVE

Integrated Network Pharmacology and Proteomics to Reveal the Molecular Therapeutic Effects of Buyang Huanwu Decoction on Ischemic Stroke

Ischemic stroke (IS), as a common cerebrovascular disease, is characterized by high disability, mortality, recurrence, and complications. Studies have shown that Buyang Huanwu Decoction (BHD) can impact the treatment of acute cerebral infarction, subsequent recovery, and sequelae. However, the mecha...

ORGANISM(S): Rattus Rattus

2022-03-11 | PXD032189 |

Asymmetric dimethylarginine proteome of pancreatic ductal adenocarcinoma.

Protein arginine methylation has been established an essential protein modification regulating cancer initiation and progression, but its implications in PDAC (Pancreatic ductal adenocarcinoma) still remains poorly elucidated. In this study, we characterized ADMA (asymmetric dimethylarginine)-bearin...

ORGANISM(S): Homo Sapiens

2020-02-18 | PXD017577 |

Stellettin B renders glioblastoma vulnerable to poly (ADP-ribose) polymerase inhibitors via suppressing homology-directed repair

Glioblastoma (GBM) is the most malignant tumor of the central nervous system. Current first-line post-surgery regimens for GBM including radiotherapy and temozolomide (TMZ) chemotherapy show very limited efficacy, with a median overall survival of only 15 months. Therefore, the development of therap...